ストックスクリーナーアプリを入手
48.48
0.29%
-0.1071
前日終値:
$48.59
開ける：
$48.56
24時間の取引高:
347.20K
Relative Volume:
0.22
時価総額：
$6.18B
収益：
$947.36M
当期純損益:
$392.47M
株価収益率:
25.79
EPS:
1.88
ネットキャッシュフロー:
$392.71M
1週間 パフォーマンス:
+1.38%
1か月 パフォーマンス:
-15.23%
6か月 パフォーマンス:
+7.54%
1年 パフォーマンス:
+22.07%
1日の値動き範囲:
$47.79
$48.83
1週間の範囲:
$47.37
$48.83
52週間の値動き範囲:
$33.15
$65.53
Halozyme Therapeutics Inc Stock (HALO) Company Profile
名前
Halozyme Therapeutics Inc
セクター
電話
(858) 794-8889
住所
12390 EL CAMINO REAL, SAN DIEGO, CA
HALO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HALO
Halozyme Therapeutics Inc
|
48.48 | 6.18B | 947.36M | 392.47M | 392.71M | 3.02 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.93 | 119.71B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.70 | 82.77B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
616.63 | 37.02B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.43 | 32.26B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.28 | 28.24B | 3.30B | -501.07M | 1.03B | -2.1146 |
Halozyme Therapeutics Inc Stock (HALO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-10-07 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-09-19 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-06-07 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2024-02-29 | 開始されました | TD Cowen | Outperform |
| 2023-07-24 | ダウングレード | Goldman | Buy → Neutral |
| 2023-07-24 | 開始されました | H.C. Wainwright | Buy |
| 2023-05-10 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2023-03-27 | 再開されました | Berenberg | Buy |
| 2023-03-16 | ダウングレード | SVB Securities | Outperform → Market Perform |
| 2022-12-21 | 再開されました | Morgan Stanley | Overweight |
| 2022-11-28 | 開始されました | Wells Fargo | Overweight |
| 2022-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2022-05-23 | 開始されました | SVB Leerink | Outperform |
| 2021-06-14 | 開始されました | Evercore ISI | Outperform |
| 2021-05-17 | 開始されました | SVB Leerink | Outperform |
| 2021-05-11 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-01-21 | 繰り返されました | The Benchmark Company | Buy |
| 2020-12-17 | 開始されました | Berenberg | Buy |
| 2020-09-14 | 再開されました | JP Morgan | Overweight |
| 2020-07-01 | 開始されました | The Benchmark Company | Buy |
| 2020-02-05 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2020-01-09 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2020-01-08 | 開始されました | Goldman | Buy |
| 2019-11-05 | アップグレード | Barclays | Underweight → Equal Weight |
| 2018-10-19 | 再開されました | Piper Jaffray | Neutral |
| 2018-05-11 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2018-01-24 | 開始されました | Goldman | Neutral |
| 2017-10-16 | 繰り返されました | Piper Jaffray | Overweight |
| 2017-01-06 | ダウングレード | Citigroup | Buy → Neutral |
| 2016-11-03 | 開始されました | Deutsche Bank | Buy |
| 2015-12-04 | 開始されました | Wells Fargo | Outperform |
| 2015-11-18 | 開始されました | Citigroup | Buy |
| 2015-09-22 | 開始されました | Barclays | Overweight |
| 2015-06-22 | 繰り返されました | JP Morgan | Overweight |
| 2015-03-03 | 繰り返されました | UBS | Buy |
| 2015-02-18 | 繰り返されました | MLV & Co | Buy |
| 2015-01-08 | 繰り返されました | MLV & Co | Buy |
すべてを表示
Halozyme Therapeutics Inc (HALO) 最新ニュース
Halozyme Phase 2 Data in Advanced Pancreas Cancer Featured in an Oral Presentation at ASCO - Marketscreener.com
Edgestream Partners L.P. Purchases 46,352 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
Hantz Financial Services Inc. Invests $9.26 Million in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
CreativeOne Wealth LLC Makes New Investment in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
San Diego’s Halozyme withdraws $2.1B Evotec bid, just one week after making offer - MSN
Townsquare Capital LLC Purchases 44,044 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
Evotec shares surge 20% on Halozyme's 2 billion euro takeover bid - MSN
Halozyme abandons Evotec bid - Speciality Chemicals Magazine
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Purchased by Glenmede Trust Co. NA - MarketBeat
Halozyme Therapeutics (NASDAQ:HALO) Seems To Use Debt Rather Sparingly - Simply Wall St
Fisher Asset Management LLC Has $18.55 Million Stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
32,942 Shares in Halozyme Therapeutics, Inc. (NASDAQ:HALO) Purchased by RPg Family Wealth Advisory LLC - MarketBeat
Halozyme to Present at Upcoming Investor Conferences - Quantisnow
Swedbank AB Decreases Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
Charles Schwab Investment Management Inc. Trims Stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
Finansavisen - Finansavisen
Halozyme: Growth Amid Uncertainty After Failed Acquisition (Rating Downgrade) (HALO) - Seeking Alpha
HALO Withdraws Acquisition Bid for EVO, Reaffirms '24 View, Stock Up - MSN
Halozyme abandons its €2bn pursuit of Evotec - pharmaphorum
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Bought by Intech Investment Management LLC - MarketBeat
Halozyme eyes continuous manufacturing platform in $2.1bn Evotec bid - BioProcess Insider
Halozyme withdraws $2.1 billion buyout offer for Evotec - MSN
Brokerages Set Halozyme Therapeutics, Inc. (NASDAQ:HALO) Price Target at $61.11 - MarketBeat
Here's Why Halozyme Therapeutics (HALO) is a Strong Value Stock - MSN
Halozyme Therapeutics (NASDAQ:HALO) Sees Large Volume IncreaseShould You Buy? - MarketBeat
Where are the Opportunities in (HALO) - Stock Traders Daily
Halozyme shares jump 12% as it scraps $2.1 bln Evotec deal - MSN
BRIEF—Halozyme withdraws non-binding offer for Evotec - The Pharma Letter
Halozyme ends bid to acquire Evotec at €2 billion valuation By Investing.com - Investing.com Australia
Halozyme Withdraws Proposal To Buy Evotec, Citing ‘Unwillingness To Engage’ - Citeline News & Insights
Halozyme Therapeutics (HALO) Upgraded to Buy: Here's Why - MSN
Halozyme Withdraws Evotec Bid After Rebuff, Reaffirms Strong Growth Outlook - AOL
Halozyme Pulls €2B Bid After Evotec Fails To Engage In Talks - Law360
Halozyme withdraws $2.1 bln buyout offer for German drug developer Evotec - Reuters
Evotec SE (EVO) Comment on Withdrawn Non-Binding Offer from Halozyme (HALO) - StreetInsider.com
Evotec takes notice of Halozyme withdrawal, convicted in standalone strategy - TipRanks
Halozyme ends bid to acquire Evotec at €2 billion valuation - Investing.com India
Evotec plummetsHalozyme withdraws purchase bid - Marketscreener.com
Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term - Yahoo Finance
Halozyme Withdraws Bid For Evotec - Contract Pharma
Halozyme stock gains after pulling Evotec bid (HALO:NASDAQ) - Seeking Alpha
Halozyme Withdraws Bid to Purchase Drug Developer Evotec - Bloomberg
Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions - Longview News-Journal
B. Metzler seel. Sohn & Co. Holding AG Invests $1.90 Million in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
Halozyme drops Evotec buyout bid; Patient dies in Neurogene trial - Yahoo Finance
Thrivent Financial for Lutherans Has $13.34 Million Stock Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
Natixis Advisors LLC Raises Stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
It has been confirmed that Merck (MSD), a large global pharmaceutical company, has filed a patent in.. - 매일경제
San Diego biotech Halozyme makes $2.1B bid for German drugmaker - The San Diego Union-Tribune
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Sold by Aurora Investment Counsel - MarketBeat
Segall Bryant & Hamill LLC Raises Stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
Halozyme Therapeutics Inc (HALO) 財務データ
収益
当期純利益
現金流量
EPS
Halozyme Therapeutics Inc (HALO) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER |
Oct 15 '24 |
Option Exercise |
18.15 |
10,000 |
181,455 |
183,756 |
| LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER |
Oct 15 '24 |
Sale |
53.75 |
10,000 |
537,469 |
173,756 |
| LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER |
Oct 16 '24 |
Sale |
53.26 |
10,000 |
532,590 |
173,756 |
1.09%
0.92%
大文字化:
|
ボリューム (24 時間):